Top Markets
Coin of the day
ERYTECH Pharma S.A. ERYTECH Pharma S.A.

ERYTECH Pharma S.A.

ERYP
Peringkat dalam Saham #24698
ERYTECH Pharma S.A. is a clinical-stage biopharmaceutical company focused on... ERYTECH Pharma S.A. is a clinical-stage biopharmaceutical company focused on creating innovative therapies derived from red blood cells. These treatments target various types of cancer and rare (orphan) diseases, with the company operating in both France and the United States. Its primary experimental drug, eryaspase, is currently undergoing Phase 3 clinical trials for patients battling second-line pancreatic cancer. Furthermore, this candidate is also in Phase 2 development for triple-negative breast cancer and for individuals with second-line acute lymphoblastic leukemia. The company is additionally advancing erymethionase, a preclinical-stage product. This candidate utilizes methionine-gamma-lyase, encased within red blood cells, to specifically address cancers that are dependent on methionine for growth. Established in 2004, ERYTECH Pharma's corporate headquarters are situated in Lyon, France.
Harga Saham
$0.95011029
Terakhir disinkronkan: 2023-06-28
Kapitalisasi Pasar
$57.72M
Perubahan (1 hari)
8.53%
Perubahan (1 tahun)
0.00%
Negara
FR
Perdagangan ERYTECH Pharma S.A. (ERYP)

Kategori

Riwayat harga saham ERYTECH Pharma S.A. (ERYP)
Harga penutupan tertinggi: $0.90 pada 2023-06-01

Harga penutupan terendah: $14.08 pada 2013-05-01
Riwayat harga saham ERYTECH Pharma S.A. dari 2013 hingga 2026
Performa harga saham tahunan
Tahun Performa
2023 73.43%
2022 -78.67%
2021 -73.09%
2020 82.31%
2019 -31.19%
2018 -67.04%
2017 59.44%
2016 -51.05%
2015 -15.86%
2014 158.90%
2013 0.00%
Harga saham perusahaan atau pesaing serupa
Perusahaan Harga saham Perubahan 1th% Negara
$552.00 38.88%
US
$1.05K 58.34%
NL
$152.13 480.21%
US
$118.70 -18.24%
AU
$769.41 9.73%
CH